Emcure Pharma, led by Shark Tank India's Namita Thapar, has received SEBI approval for an IPO, expected within two months. The IPO includes ₹800 crore in new equity and an offer for sale of 1.36 crore shares.

During a Reddit "Ask Me Anything" session, Namita Thapar, a judge on Shark Tank India, revealed that she would have pursued teaching if she had not become a businesswoman.

Namita Thapar is a well-known Indian entrepreneur who has made significant contributions to the healthcare industry as the CEO of Emcure